Melanoblast Development and Associated Disorders

The Pigmentary System: Physiology and Pathophysiology: Second Edition

Volumn , Issue , 2007, Pages 140-154

  Spritz, Richard A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Etiology; Gametogenesis; Piebaldism; Tyrosine kinase; Waardenburg syndrome

Indexed keywords

EID: 75149162675     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987100.ch6     Document Type: Chapter

References (253)

1. Amiel, J., T. Attie, D. Jan, A. Pelet, P. Edery, C. Bidaud, D. Lacombe, P. Tam, J. Simeoni, E. Flori, C. Nihoul-Fekete, A. Munnich, and S. Lyonnet, S. Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum. Mol. Genet. 5:355-357, 1996.
2. Angrist, M., S. Bolk, B. Thiel, E. G. Puffenberger, R. M. Hofstra, C. H. C. M. Buys, D. T. Cass, and A. Chakravarti. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum. Mol. Genet. 4:821-830, 1995.
3. Arias, S. Genetic heterogeneity in the Waardenburg syndrome. Birth Defects Orig. Art. Ser. 7:87-101, 1971.
4. Arinami, T., M. Ishikawa, A. Inoue, M. Yanagisawa, T. Masaki, M. C. Yoshida, and H. Hamaguchi. Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23-p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.20q13.3. Am. J. Hum. Genet. 48:990-996, 1991.
5. Asher, J. H., Jr., R. Morell, and T. B. Friedmann. Waardenburg syndrome (WS): The analysis of a single family with a WS1 mutation showing linkage to RFLP markers on human chromosome 2q. Am. J. Hum. Genet. 48:43-52, 1991.
6. Asher, J. H., Jr., A. Sommer, R. Morell, and T. B. Friedman. Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome. Hum. Mutat. 7:30-35, 1996.
7. Attie, T., M. Till, A. Pelet, J. Amiel, P. Edery, L. Boutrand, A. Munnich, and S. Lyonnet. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum. Mol. Genet. 4:2407-2409, 1995 a.
8. Attie, T., A. Pelet, P. Edery, C. Eng, L. M. Mulligan, J. Amiel, L. Boutrand, C. Beldjord, C. Nihoul-Fekete, A. Munnich, B. A. Ponder, and S. Lyonnet. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum. Mol. Genet. 4:1381-1386, 1995 b.
9. Auerbach, R. Analysis of the developmental effects of a lethal mutation in the house mouse. J. Exp. Zool. 127:305-330, 1954.
10. Ayme, S. and N. Philip. Possible homozygous Waardenburg syndrome in a fetus with exencephaly. Am. J. Med. Genet. 59:263-265, 1995.
11. Baldwin, C. T., C. F. Hoth, J. A. Amos, E. O. daSilva, and A. Milunsky. An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature 355:637-639, 1992.
12. Baldwin, C. T., N. Lipsky, C. Hoth, T. Cohen, W. Mamuya, and A. Milunsky. Mutations in PAX3 associated with Waardenburg syndrome type I. Hum. Mutat. 3:205-211, 1994.
13. Baldwin, C. T., C. F. Hoth, R. A. Macina, and A. Milunsky. Mutations in PAX3 that cause Waardenburg syndrome type I: Ten new mutations and review of the literature. Am. J. Med. Genet. 58:115-122, 1995.
14. Barr, F. G., N. Galili, J. Holick, J. A. Biegel, G. Rovera, and B. S. Emanuel. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet. 3:113-117, 1993.
15. Barsh, G. S. Pigmentation, pleiotropy and genetic pathways in humans and mice. Am. J. Hum. Genet. 57:743-747, 1995.
16. Baynash, A. G., K. Hosoda, A. Giaid, J. A. Richardson, N. Emoto, R. E. Hammer, and M. Yanagisawa. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79:1277-1285, 1994.
17. Beghini, A., L. Larizza, R. Cairoli, and E. Morra. C-kit activating mutations and mast cell proliferation in human leukemia. Blood 92:701-702, 1998.
18. Beghini, A., C. B. Ripamonti, R. Cairoli, G. Cazzaniga, P. Colapietro, F. Elice, G. Nadali, G. Grillo, O. A. Haas, A. Biondi, E. Morra, and L. Larizza. KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication. Haematologica 89:920-925, 2004.
19. Bennett, D. C., and M. L. Lamoreux. The color loci of mice-a genetic century. Pigment Cell Res. 16:333-344, 2003.
20. Bentley, N. J., T. Eisen, and C. R. Goding. Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol. 14:7996-8006, 1994.
21. Besmer, P., J. E. Murphy, P. C. George, F. Qiu, P. J. Bergold, L. Lederman, H. W. Snyder, Jr., D. Brodeur, E. E. Zuckerman, and W. S. Hardy. A new acute transforming feline retrovirus and the relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415-421, 1986.
22. Bidaud, C., R. Salomon, G. Van Camp, A. Pelet, T. Attie, C. Eng, M. Bonduelle, J. Amiel, C. Nihoul-Fekete, P. J. Willems, A. Munnich, and S. Lyonnet. Endothelin-3 gene mutations in isolated and syndromic Hirschsprung disease. Eur. J. Hum. Genet. 5:247-251, 1997.
23. Blechman, J. M., S. Lev, M. F. Brizzi, O. Leitner, L. Pegoraro, D. Givol, and Y. Yarden. Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor. J. Biol. Chem. 268:4399-4406, 1993.
24. Blechman, J. M., S. Lev, J. Barg, M. Eisenstein, B. Vaks, Z. Vogel, D. Givol, and Y. Yarden. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell 80:103-113, 1995.
25. Bober, E., T. Franz, H. H. Arnold, P. Gruss, and P. Tremblay. Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 120:603-612, 1994.
26. Bolk, S., M. Angrist, J. Xie, M. Yanagisawa, J. M. Silvestri, D. E. Weese-Mayer, and A. Chakravarti. Endothelin-3 frameshift mutation in congenital central hypoventilation syndrome. Nature Genet. 13:395-396, 1996.
27. Bolk Gabriel, S., R. Salomon, A. Pelet, M. Angrist, J. Amiel, M. Fornage, T. Attie-Bitach, J. M. Olson, R. Hofstra, C. Buys, J. Steffann, A. Munnich, S. Lyonnet, and A. Chakravarti. Segregation at three loci explains familial and population risk in Hirschsprung disease. Nature Genet. 31:89-93, 2002.
28. Bondurand, N., K. Kuhlbrodt, V. Pingault, J. Enderich, M. Sajus, N. Tommerup, M. Warburg, R. C. M. Hennekam, A. P. Read, M. Wegner, and M. Goossens. A molecular analysis of the Yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies. Hum. Mol. Genet. 8:1785-1789, 1999.
29. Bondurand, N., V. Pingault, D. E. Goerich, N. Lemort, E. Sock, C. Le Caignec, M. Wegner, and M. Goosens. Interaction among SOX10, PAX3, and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet. 9:1907-1917, 2000.
30. Breathnach, A. S., T. B. Fitzpatrick, and L. M. A. Wyllie. Electron microscopy of melanocytes in a case of human piebaldism. J. Invest. Dermatol. 45:28-37, 1965.
31. Broudy, V. C., N. L. Lin, and D. F. Sabath. The fifth immunoglobulinlike domain of the Kit receptor is required for proteolytic cleavage from the cell surface. Cytokine 15:188-195, 2001.
32. Burri, M., Y. Tromvoukis, D. Bopp, G. Frigeio, and M. Noll. Conservation of the paired domain in metazoans and its structure in three isolated human genes. EMBO J. 8:1183-1190, 1989.
33. Butt, J., J. Greenberg, I. Winship, S. Sellars, P. Beighton, and R. Ramesar. A splice junction mutation in PAX3 causes Waardenburg syndrome in a South African family. Hum. Mol. Genet. 3:197-198, 1994.
34. Buttner, C., B. M. Henz, P. Welker, N. T. Sepp, and J. Grabbe. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J. Invest. Dermatol. 111:1227-1231, 1998.
35. Campbell, B., and S. Swift. Partial albinism: Nine cases in six generations. JAMA 18:1103-1106, 1962.
36. Chabot, B., D. A. Stephenson, V. M. Chapman, P. Besmer, and A. Bernstein. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88-89, 1988.
37. Chalepakis, G., M. Goulding, A. Read, T. Stradchan, and P. Gruss. Molecular basis of Splotch and Waardenburg Pax-3 mutations. Proc. Natl. Acad. Sci. USA 91:3685-3689, 1994.
38. Chen, H., C. Rossier, M. D. Lalioti, A. Lynn, A. Chakravarti, G. Perrin, and S. E. Antonarakis. Cloning of the cDNA for a human homologue of the Drosophila white gene and mapping to chromosome 21q22.3. Am. J. Hum. Genet. 59:66-75, 1996.
39. Chilton-Macneill, S., M. Ho, C. Hawkins, A. Gassas, M. Zielenska, and S. Baruchel. C-kit expression and mutational analysis in medul-loblastoma. Pediatr. Dev. Pathol. 7:493-498, 2004.
40. Chompret, A., C. Kannengiesser, M. Barrois, P. Terrier, P. Dahan, T. Tursz, G. M. Lenoir, and B. Bressac-De Paillerets. PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology 126:318-321, 2004.
41. Comings, D. E., and G. F. Odland. Partial albinism. J. Am. Med. Assoc. 195:510-523, 1966.
42. Cooke, J. V. Familial white spotting (piebaldness) ("partial albinism") with white forelock. J. Pediatr. 41:1-12, 1952.
43. Copeland, N. G., D. J. Gilbert, B. C. Cho, P. J. Donovan, N. A. Jenkins, D. Cosman, D. Anderson, S. D. Lyman, and D. E. Williams. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63:175-183, 1990.
44. d'Auriol, L., M. G. Mattei, C. Andre, and F. Galibert. Localization of the human c-kit protooncogene on the q11-q12 region of chromosome 4. Hum. Genet. 78:374-376, 1988.
45. DeStefano, A. L., L. A. Cupples, K. S. Arnos, J. H. Asher, Jr., C. T. Baldwin, S. Blanton, M. L. Carey, E. O. da Silva, T. B. Friedman, J. Greenberg, A. K. Lalwani, A. Milunsky, W. E. Nance, A. Pandya, R. S. Ramear, A. P. Read, M. Tassabejhi, E. R. Wilcox, and L. A. Farrer. Correlation between Waardenburg syndrome phenotype and genotype in a population of individuals with identified PAX3 mutations. Hum. Genet. 102:499-506, 1998.
46. Duttlinger, R., K. Manova, G. Berrozpe, T. Chu, V. DeLeon, I. Timokhina, R. S. K. Changanti, A. D. Zelenetz, R. F. Bacharova, and P. Besmer. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melano-genesis in Wsh and Ph mutant mice. Proc. Natl. Acad. Sci. USA 92:3754-3758, 1995.
47. Edery, P., S. Lyonnet, L. M. Mulligan, A. Pelet, E. Dow, L. Abel, S. Holder, C. Nihoul-Fékété, B. A. J. Ponder, and A. Munnich. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367:378-380, 1994.
48. Edery, P., T. Attie, J. Amiel, A. Pelet, C. Eng, R. M. Hofstra, H. Martelli, C. Bidaud, A. Munnich, and S. Lyonnet. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nature Genet. 12:442-444, 1996.
49. Eng, C. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N. Engl. J. Med. 335:943-951, 1996.
50. Eng, C., D. P. Smith, L. M. Mulligan, M. A. Nagai, C. S. Healey, M. A. Ponder, E. Gardner, G. F. Scheumann, C. E. Jackson, A. Tunnacliffe, and B. A. J. Ponder. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum. Mol. Genet. 3:237-241, 1994.
51. Epstein, D. J., M. Vekemans, and P. Gross. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67:767-774, 1991.
52. Epstein, D. J., K. J. Vogan, D. G. Trasler, and P. Gros. A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc. Natl. Acad. Sci. USA 90:532-536, 1993.
53. Ezoe, K., S. A. Holmes, L. Ho, C. P. Bennett, J. L. Bolognia, L. Brueton, J. Burn, R. Falabella, E. M. Gatto, N. Ishii, C. Moss, M. R. Pittelkow, E. Thompson, K. A. Ward, and R. A. Spritz. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism. Am. J. Hum. Genet. 56:58-66, 1995.
54. Farrer, L. A., K. M. Grundfast, J. Amos, K. S. Arnos, J. H. Asher Jr., P. Beighton, S. R. Diehl, J. Fex, C. Foy, T. B. Friedman, J. Greenberg, C. Hoth, M. Marazita, A. Milunsky, R. Morell, W. Nance, V. Newton, R. Ramesar, T. B. San Agustin, J. Skare, C. A. Stevens, R. G. Wagner, Jr., E. R. Wilcox, I. Winship, and A. P. Read. Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: First report of the WS consortium. Am. J. Hum. Genet. 50:902-913, 1992.
55. Farrer, L. A., K. S. Arnos, J. H. Asher, Jr., C. T. Baldwin, S. R. Diehl, T. B. Friedman, J. Greenberg, K. M. Grundfast, C. Hoch, A. K. Lalwani, B. Landa, K. Leverton, A. Milunsky, R. Morell, W. E. Nance, V. Newton, R. Ramesar, V. S. Rao, J. E. Reynolds, T. B. San Agustin, E. R. Wilcox, I. Winship, and A. P. Read. Locus heterogeneity for Waardenburg syndromes is predictive of clinical subtypes. Am. J. Hum. Genet. 55:728-737, 1994.
56. Flanagan, J. G., and P. Leder. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell 63:185-194, 1990.
57. Fleischman, R. A. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene. J. Clin. Invest. 89:1713-1717, 1992.
58. Fleischman, R. A., D. L. Saltman, V. Stastny, and S. Zneimer. Deletion of the c-kit proto-oncogene in the human developmental defect piebald trait. Proc. Natl. Acad. Sci. USA 88:10885-10889, 1991.
59. Fleischman, R. A., T. Gallardo, and X. Mi. Mutations in the ligand-binding domain of the kit receptor: an uncommon site in human piebaldism. J. Invest. Dermatol. 107:703-706, 1996.
60. Fortin, A. S., D. A. Underhill, and P. Gros. Reciprocal effect of Waar-denburg mutations on DNA binding by the Pax-3 paired domain and homeodomain. Hum. Mol. Genet. 6:1781-1790, 1997.
61. Foy, C., V. E. Newton, D. Wellesley, R. Harris, and A. R. Read. Assignment of WS1 locus to human 2q37 and possible homology between Waardenburg syndrome and the Splotch mouse. Am. J. Hum. Genet. 46:1017-1023, 1990.
62. Franz, T., R. Kothary, M. Surani, Z. Halata, and M. Grim. The splotch mutation interferes with muscle development in limbs. Anat. Embryol. Berl. 187:153-160, 1993.
63. Fredericks, W. J., N. Galili, S. Mukhopadhyay, G. Rovera, J. Bennicelli, F. G. Barr, and F. J. Rauscher, III. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell. Biol. 15:1522-1535, 1995.
64. Froggat, P. An outline with bibliography of human piebaldism. Ir. J. Med. Sci. 398:86-94, 1951.
65. Fukai, K., T. Hamada, M. Ishii, J.-I. Kitajima, and Y. Terao. Acquired pigmented macules in human piebald lesions: Ultrastructure of melanocytes in hypopigmented skin. Acta Derm. Venereol. 69:524-527, 1989.
66. Funderburk, S. J., and B. F. Crandall. Dominant piebald trait in a retarded child with a reciprocal translocation and small intercalary deletion. Am. J. Hum. Genet. 46:715-722, 1974.
67. Furitsu, T., T. Tsujimura, T. To no, H. Ikeda, H. Kitayama, U. Koshimizu, H. Sugahara, J. H. Butterfield, L. K. Ashman, Y. Kanayama, Y. Matsuzawa, Y. Kitamura, and Y. Kanakura. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J. Clin. Invest. 92:1736-1744, 1993.
68. Galili, N., R. J. Davis, W. J. Fredericks, S. Mukhopadhyay, F. J. Rauscher, B. S. Emanuel, G. Rovera, and F. G. Barr. Fusion of a fork head domain gene to PAX3 in the solid tumor alveolar rhabdomyosarcoma. Nature Genet. 5:230-235, 1993.
69. Garver, K. L., Law, J. C., and Garver, B. Hirschsprung disease: a genetic study. Clin. Genet. 28:503-508, 1985.
70. Geerts-Marchandise, M., and J. M. Lachapelle. Piebaldisme (albinisme partiel): a propos de deux cas. Dermatologica 155:185-189, 1977.
71. Geissler, E. N., M. A. Ryan, and D. E. Housman. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55:185-192, 1988.
72. Giebel, L. B., and R. A. Spritz. Mutation of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Proc. Natl. Acad. Sci. USA 88:8696-8699, 1991.
73. Giebel, L. B., K. M. Strunk, S. A. Holmes, and R. A. Spritz. Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene 7:2207-2217, 1992.
74. Gopal Rao, V. V. N., C. Loffler, and I. Hansmann. The gene for the novel vasoactive peptide endothelin 3 (EDN3) is localized to human chromosome 20q13.2-qter. Genomics 10:840-841, 1991.
75. Goulding, M. D., G. Chalepakis, U. Deutsch, J. R. Erselius, and P. Gruss. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10:1135-1147, 1991.
76. Goulding, M. D., S. Sterrer, J. Fleming, R. Balling, J. Nadeau, K. J. Moore, S. D. M. Brown, K. P. Steel, and P. Gruss. Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics 17:355-363, 1993.
77. Gross, A., J. Kunze, R. F. Maier, G. Stoltenburg-Didinger, I. Grimmer, and M. Obladen. Autosomal-recessive neural crest syndrome with albinism, black lock, cell migration disorder of the neurocytes of the gut, and deafness: ABCD syndrome. Am. J. Med. Genet. 56: 322-326, 1995.
78. Grupper, C., M. Prunieras, M. Hincky, and E. Garelly. Albinisme partiel familial (piebaldisme): etude ultrastructurale. Ann. Dermatol. Venereol. 97:267-286, 1970.
79. Hayashi, S.-I., T. Kusiniada, M. Ogawa, K. Yamaguchi, and S.-I. Nishikawa. Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. Nucleic Acids Res. 19:1267-1271, 1991.
80. Hemesath, T. J., E. Steingrimsson, G. McGill, M. J. Hansen, J. Yaught, C. A. Hodgkinson, H. Arnheiter, N. G. Copeland, N. A. Jenkins, and D. E. Fisher. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 8:2770-2780, 1994.
81. Herbarth, B., V. Pingault, N. Bondurand, K. Kuhlbrodt, I. Hermans-Borgmeyer, A. Puliti, N. Lemort, M. Goossens, and M. Wegner. Mutation of the Sry-related Sox10 gene in dominant megacolon, a mouse model for human Hirschsprung disease. Proc. Natl. Acd. Sci. USA 95:5161-5165, 1998.
82. Hirota S., K. Isozaki, Y. Moriyama, K. Hashimoto, T. Nishida, S. Ishiguro, K. Kawano, M. Hanada, A. Kurata, M. Takeda, G. Muhammad Tunio, Y. Matsuzawa, Y. Kanakura, Y. Shinomura, and Y. Kitamura. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 23:577-580, 1998.
83. Hirota, S., Ohashi, A., Nishida, T., Isozaki, K., Kinoshita, K., Shinomura, Y., and Kitamura, Y. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology 125:660-667, 2003.
84. Hodgkinson, C. A., K. J. Moore, A. Nakayama, E. Steingrimsson, N. G. Copeland, N. A. Jenkins, and H. Arnheiter. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74:395-404, 1993.
85. Hofstra, R. M., J. Osinga, G. Tan-Sindhunata, Y. Wu, E.-J. Kamsteeg, R. P. Wstulp, C. van Ravenswaaij-Arts, D. Majoor-Krakauer, M. Angrist, A. Chakravarti, C. Meijers, and C. H. C. M. Buys. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nature Genet. 12:445-447, 1996.
86. Hornyak, T. J., D. J. Hayes, L. Y. Chiu, and E. B. Ziff. Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech. Dev. 101:47-59, 2001.
87. Hoo, J. J., R. H. Haslam, and C. van Orman. Tentative assignment of piebald trait gene to chromosome band 4q12. Hum. Genet. 73:230-231, 1986.
88. Hood, O. J., M. Doyle, A. A. Hebert, and D. G. Oelberg. Association of Waardenburg syndrome type II and a de novo balanced 7;20 translocation. Dysmorphol. Clin. Genet. 3:122-123, 1989.
89. Hosoda, K., R. E. Hammer, J. A. Richardson, A. G. Baynash, J. C. Cheung, A. Giaid, and M. Yanagisawa. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79:1267-1276, 1994.
90. Hoth, C. F., A. Milunsky, N. Lipsky, R. Sheffer, S. K. Clarren, and C. T. Baldwin. Mutations in the paired domain of the human PAX-3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waar-denburg syndrome type I (WS1). Am. J. Hum. Genet. 52:455-462, 1993.
91. Huang, E., K. Nocka, D. R. Beler, T. Y. Chu, J. Buck, H. W. Lahm, D. Wellner, P. Leder, and P. Besmer. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225-233, 1990.
92. Hughes, A. E., V. E. Newton, X. Z. Liu, and A. P. Read. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nature Genet. 7:509-512, 1994.
93. Inoue, K., Y. Tanabe, and J. R. Lupski. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann. Neurol. 46:313-318, 1999.
94. Inoue, K., K. Shilo, C. F. Boerkoel, C. Crowe, J. Sawady, J. R. Lupski, and D. P. Agamanolis. Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease: phenotypes linked by SOX10 mutation. Ann. Neurol. 52:836-842, 2002.
95. Inoue, K., M. Khajavi, T. Ohyama, S. Hirabayashi, J. Wilson, J. D. Reggin, P. Mancias, I. J. Butler, M. F. Wilkinson, M. Wegner, and J. R. Lupski. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nature Genet. 36:361-369, 2004.
96. Ishikiriyama, S., H. Tonoki, Y. Shibuya, S. Chin, N. Harada, K. Abe, and N. Niikawa. Waardenburg syndrome type I in a child with de novo inversion (2)(q35q37.3). Am. J. Med. Genet. 33:505-507, 1989.
97. Jahr, H. M., and M. S. McIntire. Piebaldness, of familial white skin spotting (partial albinism). Am. J. Dis. Child. 88:481-484, 1954.
98. Jiang, X., O. Gurel, E. A. Mendiaz, G. W. Stearns, C. L. Clogston, H. S. Lu, T. D. Osslund, R. S. Syed, K. E. Langley, and W. A. Hendrickson. Structure of the active core of human stem cell factor and analysis of binding to its receptor kit. EMBO J. 19:3192-3203, 2000.
99. Jimbow, K., T. B. Fitzpatrick, G. Szabo, and Y. Hori. Congenital circumscribed hypomelanosis: A characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus and piebaldism. J. Invest. Dermatol. 64:50-62, 1975.
100. Jones, K. L., D. W. Smith, M. A. S. Harvey, B. D. Hall, and L. Quan. Older paternal age and fresh gene mutation: data on additional disorders. J. Pediatr. 86:84-88, 1975.
101. Keeler, C. E. The heredity of a congenital white spotting in Negroes. J. Am. Med. Assoc. 103:179-180, 1934.
102. Khan, J., M. L. Bittner, L. H. Saal, U. Teichmann, D. O. Azorsa, G. C. Gooden, W. J. Pavan, J. M. Trent, and P. S. Meltzer. CDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. USA 96:1364-13269, 1999.
103. Kimura, A., Y. Nakata, O. Katoh, and H. Hyodo. C-kit point mutation in patients with myeloproliferative disorders. Leuk. Lymphoma 25:281-287, 1997.
104. Kuhlbrodt, K., C. Schmidt, E. Sock, V. Pingault, N. Bondurand, M. Goosens, and M. Wegner. Functional analysis of Sox10 mutations found in human Waardenburg-Hirschprung patients. J. Biol. Chem. 273:23033-23038, 1998.
105. Kusafuka, T., Y. Wang, and P. Puri. Novel mutations of the endothe-lin-B receptor gene in isolated patients with Hirschsprung's disease. Hum. Mol. Genet. 5:347-349, 1996.
106. Küster, W. G. Piebaldismus. Hautarzt 38:481-483, 1987.
107. Lacassie, Y., T. F. Thurmon, M. D. Tracy, and M. Z. Pelias. Piebald trait in a retarded child with interstitial deletion of chromosome 4. Am. J. Hum. Genet. 29:641-642, 1977.
108. Lagutine, I., S. J. Conway, J. Sublett, and G. C. Grosveld. Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors. Mol. Cell. Biol. 22:7204-7216, 2002.
109. Lalwani, A. K., C. T. Baldwin, R. Morell, T. B. Friedman, T. B. San Agustin, A. Milunsky, R. Adair, J. H. Asher, E. R. Wilcox, and L. A. Farrer. A locus for Waardenburg syndrome type II maps to chromosome 1p13.3-2.1. Am. J. Hum. Genet. 55:A14, 1994.
110. Lalwani, A. K., A. Attaie, F. T. Randolph, D. Deshmukh, C. Wang, A. Mhatre, and E. Wilcox. Point mutation in the MITF gene causing Waardenburg syndrome type II in a three-generation Indian family. Am. J. Med. Genet. 80:406-409, 1998.
111. Larue, L., N. Dougherty, S. Porter, and B. Mintz. Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation. Proc. Natl. Acad. Sci. USA 89:7816-7820, 1992.
112. Lasota, J., M. Jasinski, M. Sarlomo-Rikala, and M. Miettinen. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am. J. Pathol. 154:53-60, 1999.
113. Lasota, J., A. Wozniak, M. Sarlomo-Rikala, J. Rys, R. Kordek, A. Nassar, L. H. Sobin, and M. Miettinen. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. Am. J. Pathol. 157:1091-1095, 2000.
114. Lasota, J., A. Dansonka-Mieszkowska, L. H. Sobin, and M. Miettinen. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab. Invest. 84:874-883, 2004.
115. Lassus, H., H. Sihto, A. Leminen, S. Nordling, H. Joensuu, N. N. Nupponen, and R. Butzow. Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma. Br. J. Cancer 91:2048-2055, 2004.
116. Lee, M., J. Goodall, C. Verastegui, R. Ballotti, and C. R. Goding. Direct regulation of the microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J. Biol. Chem. 275:37978-37983, 2000.
117. Lemmon, M. A., D. Pinchasi, M. Zhou, I. Lax, and J. Schlessinger. Kit receptor dimerization is driven by bivalent binding of stem cell factor. J. Biol. Chem. 272:6311-6317, 1997.
118. Lev, S., Y. Yarden, and D. Givol. Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. J. Biol. Chem. 267:15970-15977, 1992.
119. Lev, S., J. Blechman, S. I. Nisikawa, D. Givol, and Y. Yarden. Interspecies molecular chimeras of kit help define the binding site of the stem cell factor. Mol. Cell Biol. 13:2224-2234, 1993.
120. Longley, B. J., Jr., G. S. Morganroth, L. Tyrrell, T. G. Ding, D. M. Anderson, D. E. Williams, and R. Halaban. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N. Engl. J. Med. 328:1302-1307, 1993.
121. Longley, B. J., L. Tyrrell, S.-Z. Lu, Y. S. Ma, K. Langley, T. G. King, T. Duffy, P. Jacobs, L. H. Tang, and I. Modlin. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nature Genet. 12:312-314, 1996.
122. Lu-Kuo, J., D. C. Ward, and R. A. Spritz. Fluorescence in situ hybridization mapping of 25 markers on distal human chromosome 2q surrounding the human Waardenburg syndrome, type I (WS1) locus (PAX3 gene). Genomics 16:173-179, 1993.
123. Lyon, M., and A. G. Searle. Genetic Variants and Strains of the Laboratory Mouse. Oxford: Oxford University Press, 1989.
124. Lyonnet, S., A. Bolino, A. Pelet, L. Abel, C. Nihoul-Fekete, M. L. Briard, V. Mok-Siu, H. Kaariainen, G. Martucciello, M. Lerone, A. Puliti, Y. Luo, J. Weissenbach, M. Devoto, A. Munnich, and G. Romeo. A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nature Genet. 4:346-350, 1993.
125. Mackenzie, M. A., S. A. Jordan, P. S. Budd, and I. J. Jackson. Activation of the receptor tyrosinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev. Biol. 192:99-107, 1997.
126. Mahaffey, S. M., L. W. Martin, A. J. McAdams, R. C. Ryckman, and M. Torres. Multiple endocrine neoplasia type IIB with symptoms suggesting Hirschsprung's disease: a case report. J. Pediatr. Surg. 25:101-103, 1990.
127. Margolis, E. A new hereditary syndrome-sex-linked deaf-mutism associated with total albinism. Acta Genet. Stat. Med. 12:12-19, 1962.
128. Marsh, D. J., S. D. Andrew, C. Eng, D. L. Learoyd, A. G. Capes, R. Pojer, A. L. Richardson, C. Houghton, L. M. Mulligan, B. A. Ponder, and B. G. Robinson. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma. Cancer Res. 56:1241-1243, 1996.
129. Medema, R. H., G. J. P. L. Kops, J. L. Bos, and B. M. T. Burgering. AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27(kip1). Nature 404:782-787, 2000.
130. Metaxa-Mariatou, V., S. Papadopoulos, E. Papadopoulou, O. Passa, T. Georgiadis, P. Arapadoni-Dadioti, V. Leondara, and G. Nasioulas. Molecular analysis of GISTs: evaluation of sequencing and dHPLC. DNA Cell Biol. 23:777-782, 2004.
131. Miettinen, M., M. Sarlomo-Rikala, and J. Lasota. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod. Pathol. 13:536-541, 2000.
132. Milunsky, A., N. Lipsky, R. Sheffer, J. Zlotogora, and C. Baldwin. A mutation in the Waardenburg syndrome (WS-I) gene in a family with "WS-III". Am. J. Hum. Genet. 51:A222, 1992.
133. Moase, C. E., and D. G. Trasler. Splotch locus mouse mutants: models for neural tube defects and Waardenburg syndrome type 1 in humans. J. Med. Genet. 29:145-151, 1992.
134. Modur, V., R. Nagarajan, B. M. Evers, and J. Milbrandt. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression: implications for PTEN mutation in prostate cancer. J. Biol. Chem. 277:47928-47937, 2002.
135. Moore, K. J. Insight into the microphthalmia gene. Trends Genet. 11:442-448, 1995.
136. Morell, R., T. B. Friedman, S. Moelijopawiro, S. Hartono, and J. H. Asher, Jr. A frameshift mutation in the HUP2 paired domain of the probable human homolog of murine PAX-3 is responsible for Waar-denburg syndrome type I in an Indonesian family. Hum. Mol. Genet. 1:243-247, 1992.
137. Morell, R., T. Friedman, and J. Asher. A plus-one frameshift mutation in PAX3 alters the entire deduced amino acid sequence of the paired box in a Waardenburg syndrome type I (WS1) family. Hum. Mol. Genet. 2:1487-1488, 1993.
138. Morell, R., R. A. Spritz, L. Ho, J. Pierpont, W. Guo, T. B. Friedman, and J. H. Asher, Jr. Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA). Hum. Mol. Genet. 6:659-664, 1997.
139. Morrison-Graham, K., and Y. Takahashi. Steel factor and c-kit receptor: from mutants to a growth factor system. Bioessays 15:77-83, 1993.
140. Mulligan, L. M., J. B. J. Kwok, C. S. Healey, M. J. Elsdon, C. Eng, E. Gardner, D. R. Love, S. E. Mole, J. K. Moore, L. Papi, M. A. Ponder, H. Telenius, A. Tunnacliffe, and B. A. J. Ponder. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460, 1993.
141. Mulligan, L. M., C. Eng, C. S. Healey, D. Clayton, J. B. J. Kwok, E. Gardner, M. A. Ponder, A. Frilling, C. E. Jackson, H. Lehnert, H. P. H. Neumann, S. N. Thibodeau, and B. A. J. Ponder. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN2A and FMTC. Nature Genet. 6:70-74, 1994.
142. Murakami, T., K. Fukai, N. Oiso, N. Hosomi, A. Kato, C. Garganta, A. Barnicoat, F. Poppelaars, R. Aquaron, A. S. Paller, and M. Ishii. New KIT mutations in patients with piebaldism. J. Dermatol. Sci. 35:29-33, 2004.
143. Murphy, M., K. Reid, D. E. Williams, S. D. Lyman, and P. F. Bartlett. Steel factor is required for maintenance, but not differentiation, of melanocyte precursors in the neural crest. Dev. Biol. 153:396-401, 1992.
144. Nagata, H., A. S. Worobec, C. K. Oh, B. A. Chowdhury, S. Tannenbaum, Y. Suzuki, and D. D. Metcalfe. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl. Acad. Sci. USA 92:10560-10564, 1995.
145. Nagle, D. L., P. Martin-DeLeon, R. B. Hough, and M. Bucan. Structural analysis of chromosomal rearrangements associated with the developmental mutations Ph, W19H, and Rw on mouse chromosome 5. Proc. Natl. Acad. Sci. USA 91:7237-7241, 1994.
146. Nakahara, M., K. Isozaki, S. Hirota, J. Miyagawa, N. Hase-Sawada, M. Taniguchi, T. Nishida, S. Kanayama, Y. Kitamura, Y.Shinomura, and Y. Matsuzawa. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology 115:1090-1095, 1998.
147. Nakamura, N., S. Ramaswamy, F. Vazaquez, S. Signoretti, M. Loda, and W. R. Sellers. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20:8969-8982, 2000.
148. Nakata, Y., A. Kimura, O. Katoh, K. Kawaishi, H. Hyodo, K. Abe, A. Kuramoto, and Y. Satow. C-kit point mutation of extracellular domain in patients with myeloproliferative disorders. Br. J. Haematol. 91:661-663, 1995.
149. Nishida, T., S. Hirota, M. Taniguchi, K. Hashimoto, K. Isozaki, H. Nakamura, Y. Kanakura, T. Tanaka, A. Takabayashi, H. Matsuda, and Y. Kitamura. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nature Genet. 19:323-324, 1998.
150. Nishikawa, S., M. Kusakabe, K. Yoshinaga, M. Ogawa, S.I. Hayashi, T. Kunisada, T. Era, and T. Sakakura. In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development. EMBO J. 10:2111-2118, 1991.
151. Nobukuni, Y., A. Watanabe, K. Takeda, H. Skarka, and M. Tachibana. Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A. Am. J. Hum. Genet. 59:76-83, 1996.
152. 41 and W. EMBO J. 9:1805-1813, 1990.
153. Nomura, K., I. Hatayama, T. Narita, T. Kaneko, and M. A. Shiraishi. A novel KIT gene missense mutation in a Japanese family with piebaldism. J. Invest. Dermatol. 111:337-338, 1998.
154. Pardono, E., Y. van Brever, J. van den Ende, P. C. Havrenne, P. Iughetti, S. R. P. Maestrelli, F. O. Costa, A. Richieri-Costa, O. Frota-Pessoa, and P. A. Otto. Waardenburg syndrome: clinical differentiation between types I and II. Am. J. Med. Genet. 117 A: 223-235, 2003.
155. Parichy, D. M., J. F. Rawls, S. J. Pratt, T. T. Whitfield, and S. L. Johnson. Zebrafish sparse corresponds to an orthologue of c-kit and is required for the morphogenesis of a subpopulation of melanocytes, but is not essential for hematopoiesis or primordial germ cell development. Development 126:3425-3436, 1999.
156. Pasteris, N. G., B. J. Trask, S. Sheldon, and J. L. Gorski. Discordant phenotypes of two overlapping deletions involving the PAX3 gene in chromosome 2q35. Hum. Mol. Genet. 2:953-959, 1993.
157. Passarge, E. The genetics of Hirschsprung's disease: evidence for heterogeneous etiology and a study of sixty-three families. N. Engl. J. Med. 276:138-143, 1967.
158. Pavan, W. J., and S. M. Tilghman. Piebald lethal (sl) acts early to disrupt the development of neural crest-derived melanocytes. Proc. Natl. Acad. Sci. USA 91:7159-7163, 1994.
159. Pavan, W. J., S. Mac, M. Cheng, and S. M. Tilghman. Quantitative trait loci that modify the severity of spotting in piebald mice. Genome Res. 5:29-41, 1995.
160. Pearson, K. A Monograph on Albinism in Man. London: Dulan & Co., 1913.
161. Perez-Losada, J., M. Sanchez-Martin, A. Rodriguez-Garcia, T. Flores, M. L., Sanchez, A. Orfao, and I. Sanchez-Garcia. The zinc finger transcription factor SLUG contributes to the function of the SCF-c-kit signaling pathway. Blood 100:1274-1286, 2002.
162. Philo, J. S., J. Wen, J. Wypych, M. G. Schwartz, E. A. Mendiaz, and K. E. Langley. Human stem cell factor dimer forms a complex with two molecules of the extracellular domain of its receptor, Kit. J. Biol. Chem. 22:6895-6902, 1996.
163. Pierard, G. E., C. Franchimont, and M. Lapiere. Six generations of piebaldism. J. Dermatol. Surg. Oncol. 4:916-919, 1978.
164. Pierpont, J. W., and R. P. Erickson. Facts on PAX. Am. J. Hum. Genet. 52:451-454, 1993.
165. Pingault, V., N. Bondurand, K. Kuhlbrodt, D. E.Goerich, M.-O.Prehu, A. Puliti, B. Herbarth, I. Hermans-Borgmeyer, E. Legius, G. Matthijs, J. Amiel, S. Lyonnet, I. Ceccherini, G. Romeo, J. C. Smith, A. P. Read, M. Wegner, and M. Goossens. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nature Genet. 18:171-173, 1998.
166. Potterf, S. B., M. Furumura, K. J. Dunn, H. Arnheiter, and W. J. Pavan. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum. Genet. 107:1-6, 2000.
167. Puffenberger, E. G., E. R. Kauffman, S. Bolk, T. C. Matise, S. S. Washington, M. Angrist, J. Weissenbach, K. L. Garver, M. Mascari, R. Ladda, S. A. Slaugenhaupt, and A. Chakravarti. Identity-by-descent and association mapping of a recessive gene for Hirschsprung disease on human chromosome 13q22. Hum. Mol. Genet. 3:1217-1225, 1994 a.
168. Puffenberger, E. G., K. Hosoda, S. S. Washington, K. Nakao, D. deWit, M. Yanagisawa, and A. Chakravarti. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79:1257-1266, 1994 b.
169. Rawls, J. F., and S. L. Johnson. Temporal and molecular separation of the kit receptor tyrosine kinase's roles in zebrafish melanocyte migration and survival. Dev. Biol. 262:152-161, 2003.
170. Reith, A. D., R. Rottapel, E. Giddens, C. Brady, L. Forrester, and A. Bernstein. W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. Genes Dev. 4:390-400, 1990.
171. Relaix, F., M. Polimeni, D. Rocancourt, C. Ponzetto, B. W. Schafer, and M. Buckingham. The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo. Genes Dev. 17:2950-2965, 2003.
172. Reynolds, J. E., M. L. Marazita, J. M. Meyer, C. A. Stevens, L. J. Eaves, K. S. Arnos, L. M. Ploughman, C. MacLean, W. E. Nance, and S. R. Diehl. Major-locus contributions to variability of the craniofacial feature dystopia canthorum in Waardenburg syndrome. Am. J. Hum. Genet. 58:384-392, 1996.
173. Richards, K. A., K. Fukai, N. Oiso, and A. S. Paller. A novel KIT mutation results in piebaldism with progressive depigmentation. J. Am. Acad. Dermatol. 44:228-292, 2001.
174. Ridgeway, A. G., and I. S. Skerjanc. Pax3 is essential for skeletal myo-genesis and the expression of Six1 and Eya2. J. Biol. Chem. 276:19033-19039, 2001.
175. Riva, P., N. Milani, P. Gandolfi, and L. Larizza. A 12-bp deletion (7818del12) in the c-kit protooncogene in a large Italian kindred with piebaldism. Hum. Mutat. 6:343-345, 1995.
176. Romeo, G., P. Ronchetto, Y. Luo, V. Barone, M. Seri, I. Ceccherini, B. Pasini, R. Bocciardi, M. Lerone, H. Kääriäinen, and G. Martucciello. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367: 377-378, 1994.
177. Ronnstrand, L. Signal transduction via the stem cell factor receptor/c-Kit. Cell. Mol. Life Sci. 612535-2548, 2004.
178. Russell, W. L. Splotch, a new mutation in the house mouse, Mus mus-culus. Genetics 32:102, 1947.
179. Scheidler, S., W. J. Fredericks, F. J. Rauscher, III, F. G. Barr, and P. K. Vogt. The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Proc. Natl. Acad. Sci. USA 93:9805-9809, 1996.
180. Sakurai, S., T. Hasegawa, Y. Sakuma, Y. Takazawa, A. Motegi, T. Nakajima, K. Saito, M. Fukayama, and T. Shimoda. Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Hum. Pathol. 35:1223-1230, 2004.
181. Sanchez-Martin, M., A. Rodriguez-Garcia, J. Perez-Losada, A.Sagrera, A. P. Read, and I. Sanchez-Garcia. SLUG (SNA12) deletions in patients with Waardenburg disease. Hum. Mol. Genet. 11:3231-3236, 2002.
182. Sanchez-Martin, M., J. Perez-Losada, A. Rodriguez-Garcia, B. Gonzalez-Sanchez, B. R. Korf, W. Kuster, C. Moss, R. A. Spritz, and I. Sanchez-Garcia. Deletion of the SLUG (SNA12) gene results in human piebaldism. Am. J. Med. Genet. A 122:125-132, 2003.
183. Selicorni, A., S. Guerneri, A. Ratti, and A. Pizzuti. Cytogenetic mapping of a novel locus for type II Waardenburg syndrome. Hum. Genet. 110:64-67, 2002.
184. Seri, M., L. Yin, L., A. Barone, A. Bolino, I. Celli, R. Bocciardi, B. Pasini, I. Ceccherini, M. Lerone, U. Kristoffersson, L. T. Larsson, J. M. Casasa, D. T. Cass, M. J. Abramowicz, J.-M. Vanderwinden, I. Kravcenkiene, I. Baric, M. Silengo, G. Martucciello, and G. Romeo. Frequency of RET mutations in long-and short-segment Hirschsprung disease. Hum. Mutat. 9:243-249, 1997.
185. Shah, K. N., S. J. Dalal, M. P. Desai, P. N. Sheth, N. C. Joshi, and L. M. Ambani. White forelock, pigmentary disorder of irides, and long segment Hirschsprung disease; possible variation of Waardenburg syndrome. J. Pediatr. 99:432-435, 1981.
186. Shears, D., H. Conlon, T. Murakami, K. Fukai, R. Alles, R. Trembath, and M. Bitner-Glindzicz. Molecular heterogeneity in two families with auditory pigmentary syndromes: the role of neuroimaging and genetic analysis in deafness. Clin. Genet. 65:384-389, 2004.
187. Shiloh, Y., G. Litvak, Y. Ziv, T. Lehner, L. Sandkuyl, M. Hildesheimer, V. Buchris, F. P. M. Cremers, P. Szabo, B. N. White, J. J. A. Holden, and J. Ott. Genetic mapping of X-linked albinism-deafness syndrome (ADFN) to Xq26.3-27.1. Am. J. Hum. Genet. 47:20-27, 1990.
188. Sihto, H., M. Sarlomo-Rikala, O. Tynninen, M. Tanner, L. C. Andersson, K. Franssila, N. N. Nupponen, and H. Joensuu. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J. Clin. Oncol. 23:49-57, 2005.
189. Silvers, W. K. The Coat Colors of Mice. A Model for Mammalian Gene Action and Interaction. New York: Springer-Verlag, 1979.
190. Smith, N. G., and J. Schulz. Partial albinism. Arch. Dermatol. Syphil. 71:468-470, 1955.
191. 91̃Ĩ and patch mutations on chromosome 5. Proc. Natl. Acad. Sci. USA 88:4811-4815, 1991.
192. Smith, S. D., P. M. Kelley, J. B. Kenyon, and D. Hoover. Tietz syndrome (hypopigmentation/deafness) caused by mutation of MITF. J. Med. Genet. 37:446-448, 2000.
193. Southard-Smith, E. M., L. Kos, and W. J. Pavan. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nature Genet. 18:60-64, 1998.
194. Southard-Smith, E. M., M. Angrist, J. S. Ellison, R. Agarwala, A. D. Baxevanis, A. Chakravarti, and W. J. Pavan. The Sox10 (Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. Genome Res. 9:215-225, 1999.
195. Spritz, R. A. The molecular basis of human piebaldism. Pigment Cell Res. 5:340-343, 1992.
196. Spritz, R. A. Molecular basis of piebaldism and Waardenburg syndrome. Curr. Opin. Dermatol.:78-84, 1993.
197. Spritz, R. A., and V. J. Hearing. Genetic orders of pigmentation. In: Advances in Human Genetics, 22nd edn, K. Hirschhorn, and H. Harris (eds). New York: Plenum Publishing, 1994, pp. 1-45.
198. Spritz, R. A., S. Droetto, and Y. Fukushima. Deletion of the KIT and PDGFRA genes in a patient with piebaldism. Am. J. Med. Genet. 44:492-495, 1992 a.
199. Spritz, R. A., L. B. Giebel, and S. A. Holmes. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am. J. Hum. Genet. 50:261-269, 1992 b.
200. Spritz, R. A., S. A. Holmes, R. Ramesar, J. Greenberg, D. Curtis, and P. Beighton. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism. Am. J. Hum. Genet. 51:1058-1065, 1992 c.
201. Spritz, R. A., S. A. Holmes, S. Z. Berg, J. J. Nordlund, and K. Fukai. A recurrent deletion in the KIT (mast/stem cell growth factor receptor) proto-oncogene is a frequent cause of human piebaldism. Hum. Mol. Genet. 2:1499-1500, 1993 a.
202. Spritz, R. A., S. A. Holmes, P. Itin, and W. Kuster. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. J. Invest. Dermatol. 101:22-25, 1993 b.
203. Spritz, R. A., L. Ho, and K. M. Strunk. Inhibition of proliferation of human melanocytes by a KIT antisense oligodeoxynucleotide: implications for human piebaldism and mouse dominant white spotting (W). J. Invest. Dermatol. 103:148-150, 1994 a.
204. Spritz, R. A., K. M. Strunk, S.-T. Lee, J. M. Lu-Kuo, D. C. Ward, D. LePasilier, M. R. Altherr, T. E. Dorman, and D. T. Moir. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12. Genomics 22:431-436, 1994 b.
205. Steingrimsson, E., K. J. Moore, M. L. Lamoreux, A. R. Ferré-D'Amaré, S. K. Burley, D. C. Sanders Zimring, L. C. Skow, C. A. Hodgkinson, H. Arnheiter, N. G. Copeland, and N. A. Jenkins. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nature Genet. 8:256-263, 1994.
206. Steingrimsson, E., N. G. Copeland, and N. A. Jenkins. Melanocytes and the microphthalmia transcription factor network. Annu. Rev. Genet. 38:365-411, 2004.
207. Stephenson, D. A., M. Mercola, E. Anderson, C. Y. Wang, C. D. Stiles, D. F. Bowen-Pope, and V. M. Chapman. Platelet-derived growth factor receptor alpha-subunit gene (Pdgfra) is deleted in the mouse patch (Ph) mutation. Proc. Natl. Acad. Sci. USA 88:6-10, 1991.
208. Stephenson, D. A., K. H. Lee, D. L. Nagle, C. H. Yen, A. Morrow, D. Miller, V. M. Chapman, and M. Bucan. Mouse rump-white mutation associated with an inversion of chromosome 5. Mamm. Genome 5:342-348, 1994.
209. Storkan, M. A., and J. A. Hosmer. Vitiligo associated with poliosis and ichthyosis. Arch. Dermatol. Syphil. 70:540-541, 1954.
210. Stoykova, A., and P. Gruss. Roles of Pax genes in developing and adult brain as suggested by expression patterns. J. Neurosci. 14:1395-1412, 1994.
211. Stuart, E. T., and P. Gruss. PAX genes: what's new in developmental biology and cancer? Hum. Mol. Genet. 4:1717-1720, 1995.
212. Sublett, J. E., I.-S. Jeon, and D. N. Shapiro. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator. Oncogene 11:545-552, 1995.
213. Sundfor, H. A pedigree of skin-spotting in man. J. Hered. 30:60-77, 1939.
214. Svensson, P.-J., D. Von Tell, M.-L. Molander, M. Anvret, and A. Nordenskjold. A heterozygous frameshift mutation in the endothelin-3 (EDN-3) gene in isolated Hirschsprung's disease. Pediatr. Res. 45:714-717, 1999.
215. Syrris, P., N. D. Carter, and M. A. Patton. Novel nonsense mutation of the endothelin-B receptor gene in a family with Waardenburg-Hirschsprung disease. Am. J. Med. Genet. 87:69-71, 1999.
216. Syrris, P., N. M. Malik, V. A. Murday, M. A., Patton, N. D. Carter, H. E. Hughes, and K. Metcalfe. Three novel mutations of the protooncogene KIT cause human piebaldism. Am. J. Med. Genet. 95:79-81, 2000.
217. Syrris, P., K. Heathcote, R. Carrozzo, K. Devriendt, N. Elçioglu, C. Garrett, M. McEntagart, and N. Carter. Human piebaldism: six novel mutations of the proto-oncogene KIT. Hum. Mutat. Mutation in Brief #528 Online, 2002.
218. Tachibana, M., L. A. Perez-Jurado, A. Nakayama, C. A. Hodgkinson, X. Li, M. Schneider, T. Miki, J. Fex, U. Francke, and H. Arnheiter. Cloning of MITF, the human homolog of the mouse microphthalmia gene, and assignment to human chromosome 3, region p14.1-p12.3. Hum. Mol. Genet. 3:553-557, 1994.
219. Tachibana, M., K. Takeda, Y. Nobukuni, K. Urabe, J. E. Long, K. A. Meyers, S. A. Aaronson, and T. Miki. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocytes characteristics. Nature Genet. 14:50-54, 1996.
220. Tachibana, M., Y. Kobayashi, and Y. Matsushima. Mouse models for four types of Waardenburg syndrome. Pigment Cell Res. 16: 448-454, 2003.
221. Tan, J. C., K. Nocka, P. Ray, P. Traktman, and P. Besmer. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247:209-212, 1990.
222. Tassabehji, M., A. P. Read, V. E. Newton, R. Harris, R. Balling, P. Gruss, and T. Strachan. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355:635-637, 1992.
223. Tassabehji, M., A. P. Read, V. E. Newton, M. Patton, P. Gruss, R. Harris, and T. Strachan. Mutations in the PAX3 gene causing Waar-denburg syndrome type 1 and type 2. Nature Genet. 3:26-30, 1993.
224. Tassabehji, M., V. E. Newton, K. Leverton, K. Turnbull, E. Seemanova, J. Kunze, K. Sperling, T. Strachan, and A. P. Read. PAX3 gene structure and mutations: close analogies between Waarden-burg syndrome and the Splotch mouse. Hum. Mol. Genet. 3:1069-1074, 1994 a.
225. Tassabehji, M., V. E. Newton, and A. P. Read. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nature Genet. 8:251-255, 1994 b.
226. Tassabehji, M., V. E. Newton, X.-Z. Liu, A. Brady, D. Donnai, M. Krajewska-Walasek, V. Murday, A. Norman, E. Obersztyn, W. Reardon, J. C. Rice, R. Trembath, P. Wieacker, M. Whiteford, R. Winter, and A. P. Read. The mutational spectrum in Waarden-burg syndrome. Hum. Mol. Genet. 4:2131-2137, 1995.
227. Taylor, D. R., and T. Robinson. Piebaldism. Br. J. Dermatol. 95(Suppl. 14): 43-44, 1976.
228. Taylor, M. L., and D. D. Metcalfe. Kit signal transduction. Hematol. Oncol. Clin. North Am. 14:517-535, 2000.
229. Tekin, M., J. N. Bodurtha, W. E. Nance, and A.Pandya. Waarden-burg syndrome type 3 (Klein-Waardenburg syndrome) segregating with a heterozygous deletion in the paired box domain of PAX3: a simple variant or a true syndrome? Clin. Genet. 60:301-304, 2001.
230. Tietz, W. A syndrome of deaf-mutism associated with albinism showing dominant autosomal inheritance. Am. J. Hum. Genet. 15:259-264, 1963.
231. Touraine, R. L., T. Attie-Bitach, E. Manceau, E. Korsch, P. Sarda, V. Pingault, F. Encha-Razavi, A. Pelet, J. Auge, A. Nivelon-Chevallier, A. M. Holschneider, M. Munnes, W. Doerfler, M. Goosens, A. Munnich, M. Vekemans, and S. Lyonnet. Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am. J. Hum. Genet. 66:1496-1503, 2000.
232. Tripathi, R. K., L. B. Giebel, K. M. Strunk, and R. A. Spritz. A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity. Gene Ex-press. 1:103-110, 1991.
233. Tsujimura, T., Y. Kanakura, and Y. Kitamura. Mechanisms of constitutive activation of c-kit receptor tyrosine kinase. Leukemia 11(Suppl. 3): 396-398, 1997.
234. Tsukamoto, K., T. Tohma, T. Ohta, K. Yamakawa, Y. Fukushima, Y. Nakamura, and N. Niikawa. Cloning and characterization of the inversion breakpoint at chromosome 2q35 in a patient with Waardenburg syndrome type I. Hum. Mol. Genet. 1:315-317, 1992.
235. van Camp, G., M. N. van Thienen, I. Handig, B. Van Roy, V. S. Rao, A. Milunsky, A. P. Read, C. T. Baldwin, L. A. Farrer, M. Bonduelle, L. Standaert, F. Meise, and P. J. Willems. Chromosome 13q deletion with Waardenburg syndrome: further evidence for a gene involved in neural crest function on 13q. J. Med. Genet. 32:531-536, 1995.
236. Vandenbark, G. R., C. M. DeCastro, H. Taylor, S. Dew-Knight, and R. E. Kaurman. Cloning and structural analysis of the human c-kit gene. Oncogene 7:1259-1266, 1992.
237. Verdy, M., A. M. Weber, C. C. Roy, C. L. Morin, M. Cadotte, and P. Brochu. Hirschsprung's disease in a family with multiple endocrine neoplasia type 2. J. Pediatr. Gastroenterol. Nutr. 1:603-607, 1982.
238. Verheij, J. B. G. M., J. Kunze, J. Osinga, A. J. van Essen, and R. M. W. Hofstra. ABCD syndrome is caused by a homozygous mutation in the EDNRB gene. Am. J. Med. Genet. 108:223-225, 2002.
239. Vogan, K. J., D. J. Epstein, D. G. Trasler, and P. Gros. The splotch-delayed (Spd) mouse mutant carries a point mutation within the paired box of the Pax-3 gene. Genomics 17:364-369, 1993.
240. Watanabe, A., K. Takeda, B. Ploplis, and M. Tachibana. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nature Genet. 18:283-286, 1998.
241. Wildhardt, G., A. Winterpacht, K. Hibert, H. Menger, and B. Zabel. Two different PAX3 gene mutations causing Waardenburg syndrome type I. Mol. Cell. Probes 10:229-231, 1996.
242. Winship, I., K. Young, R. Martell, R. Ramesar, D. Curtis, and P. Beighton. Piebaldism: an autonomous autosomal dominant entity. Clin. Genet. 39:330-337, 1991.
243. Wollnik, B., T. Tukel, O. Uyguner, A. Ghanbari, H. Kayserili, M. Emiroglu, and M. Yuksel-Apak. Homozygous and heterozygous inheritance of PAX3 mutations causes different types of Waarden-burg syndrome. Am. J. Med. Genet. 122 A: 42-45, 2003.
244. Wu, B., A. Milunsky, H. Wyandt, C. Hoth, C. Baldwin, and J. Skare. In situ hybridization applied to Waardenburg syndrome. Cytogenet. Cell Genet. 63:29-32, 1993.
245. Yamamoto, Y., H. Nishimoto, and S. Ikemoto. Interstitial deletion of the proximal long arm of chromosome 4 associated with father-child incompatibility within the Gc-system: Probable reduced gene dosage effect and partial piebald trait. Am. J. Med. Genet. 32:520-523, 1989.
246. Yamamoto, H., Y. Oda, K. Kawaguchi, N. Nakamura, T. Takahira, S. Tamiya, T. Saito, Y. Oshiro, M. Ohta, T. Yao, and M. Tsuneyoshi. C-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am. J. Surg. Pathol. 28:479-488, 2004.
247. Yarden, Y., W.-J. Kuang, T. Yang-Feng, L. Coussens, S. Munemitsu, T. J. Dull, E. Chen, J. Schlessinger, U. Francke, and A. Ullrich. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6:3341-3351, 1987.
248. Yasumoto, K.-I., K. Yokoyama, K. Shibata, Y. Tomita, and S. Shibahara. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol. Cell. Biol. 14:8058-8070, 1994.
249. Yavuzer, U., E. Keenan, P. Lowings, J. Vachtenheim, G. Currie, and C. R. Goding. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene 10:123-134, 1995.
250. Yoshida, H., T. Kunisada, T. Grimm, E. K. Nishimura, E. Nishioka, and S. I. Nishikawa. Review: melanocyte migration and survival controlled by SCF/c-kit expression. J. Invest. Dermatol. Symp. Proc. 6:1-5, 2001.
251. Ziprkowski, L., A. Krakowski, A. Adam, H. Costeff, and J. Sade. Partial albinism and deaf-mutism due to a recessive sex-linked gene. Arch. Dermatol. 86:530-539, 1962.
252. Zlotogora, J., I. Lerer, S. Bar-David, Z. Ergaz, and D. Abeliovich. Homozygosity for Waardenburg syndrome. Am. J. Hum. Genet. 56:1173-1178, 1995.
253. Zsebo, K. M., D. A. Williams, E. N. Geissler, V. C. Broudy, F. H. Martin, H. L. Atkins, R. Y. Hsu, N. C. Birkett, K. H. Okino, D. C. Murdock, F. W. Jacobsen, K. E. Langley, K. A. Smith, T. Takeishi, B. M. Cattanach, S. J. Galli, and S. V. Suggs. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit receptor. Cell 63:213-214, 1990.